journal article·2018-01-02Open access

Evaluating polyethyleneimine/DNA nanoparticles-mediated damage to cellular organelles using endoplasmic reticulum stress profile

Maryam Dabbaghi, Reza Kazemi Oskuee, Khadijeh Hashemi, Amir Afkhami Goli

Abstract

Gene therapy has emerged as an influential tool for treating the genetic and specific acquired disorders. Among all kinds of gene delivery systems, the cationic polymer polyethyleneimine (PEI) is considered as a promising non-viral gene delivery vector, although there are still concerns about its magnitude of cytotoxicity. While any cell insult leads to unfolded/misfolded protein accumulation and its consequent unfold protein response, evaluating the expression profile of ER-stress genes would be a sensitive indicator of cell stress. Beside cytotoxicity assays, real-time RT-PCR was used to investigate the effects of PEI nanoparticles on the endoplasmic reticulum. Treating Neuro2A cells revealed that PEI can induce cell toxicity in a concentration-dependent manner. Also, It increased the transcript levels of Grp78 (Bip), Atf4 and Chop, and splicing of Xbp1. To further optimize the transfection properties in Neuro2A cells, PEI was used to deliver a plasmid DNA containing GFP reporter. While different PEI/plasmid ratios revealed similar transfection efficiency, increasing the PEI/plasmid ratio led to induction of ER-stress markers. These results underscored that beside the effectiveness of PEI, using the lowest possible ratio of PEI/plasmid would minimize the detrimental effects of PEI on cells and confer it a beneficial therapeutic importance in nucleic acid delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · CRISPR and Genetic Engineering · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Pharmacology, Department of Basic Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran;

Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran;

Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;

Division of Biotechnology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran;

Biotechnology Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran

Funding

Ferdowsi University of Mashhad

References (32)

Show source-provided references
1. 10.1016/j.ejpb.2004.11.01110.1016/j.ejpb.2004.11.011 ↗
2. 10.1002/jgm.77310.1002/jgm.773 ↗
3. 10.1080/20016689.2017.126529310.1080/20016689.2017.1265293 ↗
4. 10.1016/j.progpolymsci.2007.05.01910.1016/j.progpolymsci.2007.05.019 ↗
5. 10.1016/S0169-409X(02)00046-710.1016/S0169-409X(02)00046-7 ↗
6. 10.1016/j.biomaterials.2009.04.03610.1016/j.biomaterials.2009.04.036 ↗
7. 10.1016/j.biomaterials.2011.07.04410.1016/j.biomaterials.2011.07.044 ↗
8. 10.1016/j.ymthe.2005.02.01010.1016/j.ymthe.2005.02.010 ↗
9. 10.1080/01932691.2013.86003410.1080/01932691.2013.860034 ↗
10. 10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.0.CO;2-R10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.0.CO;2-R ↗
11. 10.1039/c000190b10.1039/c000190b ↗
12. 10.1080/0022293070131493210.1080/00222930701314932 ↗
13. 10.1038/nri235910.1038/nri2359 ↗
14. 10.1111/j.1742-4658.2007.05639.x10.1111/j.1742-4658.2007.05639.x ↗
15. 10.1016/j.coph.2009.11.00610.1016/j.coph.2009.11.006 ↗
16. 10.1038/nrd397610.1038/nrd3976 ↗
17. 10.1038/sj.cdd.440137310.1038/sj.cdd.4401373 ↗
18. 10.2131/jts.31.14910.2131/jts.31.149 ↗
19. 10.1016/j.biomaterials.2009.09.08810.1016/j.biomaterials.2009.09.088 ↗
20. 10.1023/A:101486190047810.1023/A:1014861900478 ↗
21. 10.1016/S0168-3659(99)00090-510.1016/S0168-3659(99)00090-5 ↗
22. 10.1016/S0169-409X(01)00202-210.1016/S0169-409X(01)00202-2 ↗
23. 10.3109/0148054090349350710.3109/01480540903493507 ↗
24. 10.1016/j.jconrel.2010.10.02810.1016/j.jconrel.2010.10.028 ↗
25. 10.5012/bkcs.2007.28.1.09510.5012/bkcs.2007.28.1.095 ↗
26. 10.1016/j.jconrel.2006.04.01410.1016/j.jconrel.2006.04.014 ↗
27. 10.1038/cdd.2011.2410.1038/cdd.2011.24 ↗
28. 10.1006/taap.1999.884210.1006/taap.1999.8842 ↗
29. Gülow K · J Cell Sci · 2002 · 115 · 244310.1242/jcs.115.11.2443 ↗
30. Rosengren V · J Cell Biochem · 2012 · 113 · 163510.1002/jcb.24032 ↗
31. 10.1016/j.ijpharm.2009.12.03310.1016/j.ijpharm.2009.12.033 ↗
32. 10.1038/sj.embor.740077910.1038/sj.embor.7400779 ↗